Shu-Wen Weng

568 total citations
14 papers, 491 citations indexed

About

Shu-Wen Weng is a scholar working on Complementary and alternative medicine, Cancer Research and Molecular Biology. According to data from OpenAlex, Shu-Wen Weng has authored 14 papers receiving a total of 491 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Complementary and alternative medicine, 6 papers in Cancer Research and 5 papers in Molecular Biology. Recurrent topics in Shu-Wen Weng's work include Ginseng Biological Effects and Applications (3 papers), Protease and Inhibitor Mechanisms (3 papers) and Traditional Chinese Medicine Analysis (2 papers). Shu-Wen Weng is often cited by papers focused on Ginseng Biological Effects and Applications (3 papers), Protease and Inhibitor Mechanisms (3 papers) and Traditional Chinese Medicine Analysis (2 papers). Shu-Wen Weng collaborates with scholars based in Taiwan, United States and China. Shu-Wen Weng's co-authors include Jing‐Gung Chung, Jaung‐Geng Lin, Yi-Shih Ma, Jing-Pin Lin, Jai‐Sing Yang, Tung-Yuan Lai, Kuang‐Chi Lai, Kung-Wen Lu, Nou-Ying Tang and Chao-Lin Kuo and has published in prestigious journals such as ACS Applied Materials & Interfaces, Food and Chemical Toxicology and BMJ Open.

In The Last Decade

Shu-Wen Weng

14 papers receiving 489 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shu-Wen Weng Taiwan	12	230	75	68	63	56	14	491
Yi‐Ting Hsi Taiwan	13	283 1.2×	57 0.8×	118 1.7×	116 1.8×	51 0.9×	15	480
Yi-Shih Ma Taiwan	13	423 1.8×	107 1.4×	125 1.8×	45 0.7×	66 1.2×	14	735
Chin Cheng Su Taiwan	11	351 1.5×	65 0.9×	90 1.3×	36 0.6×	47 0.8×	13	555
SONG-SHEI LIN Taiwan	9	377 1.6×	74 1.0×	89 1.3×	29 0.5×	36 0.6×	10	599
Mengying Lv China	15	316 1.4×	75 1.0×	66 1.0×	106 1.7×	97 1.7×	41	551
Hui‐Jye Chen Taiwan	13	379 1.6×	49 0.7×	72 1.1×	30 0.5×	30 0.5×	23	599
Hyeon‐Soo Park South Korea	13	309 1.3×	115 1.5×	60 0.9×	46 0.7×	43 0.8×	22	574
Chih‐Ping Hsu Taiwan	17	351 1.5×	128 1.7×	76 1.1×	28 0.4×	33 0.6×	34	789
Jeong‐Geon Mun South Korea	14	251 1.1×	46 0.6×	80 1.2×	22 0.3×	45 0.8×	19	434

Countries citing papers authored by Shu-Wen Weng

Since Specialization

Citations

This map shows the geographic impact of Shu-Wen Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu-Wen Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu-Wen Weng more than expected).

Fields of papers citing papers by Shu-Wen Weng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu-Wen Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu-Wen Weng. The network helps show where Shu-Wen Weng may publish in the future.

Co-authorship network of co-authors of Shu-Wen Weng

This figure shows the co-authorship network connecting the top 25 collaborators of Shu-Wen Weng. A scholar is included among the top collaborators of Shu-Wen Weng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu-Wen Weng. Shu-Wen Weng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Weng, Shu-Wen, Chuen‐Chau Chang, Ta-Liang Chen, et al.. (2020). Risk of diabetes in stroke patients who used Bu Yang Huan Wu Tang: A nationwide propensity-score matched study. Phytomedicine. 80. 153376–153376. 6 indexed citations

Luo, Dian, Shu-Wen Weng, Chin‐Wei Lu, et al.. (2020). Combinational Approach To Realize Highly Efficient Light-Emitting Electrochemical Cells. ACS Applied Materials & Interfaces. 12(12). 14254–14264. 31 indexed citations

Weng, Shu-Wen, et al.. (2018). The effects of Bu Yang Huan Wu Tang on post-stroke epilepsy: a nationwide matched study. Clinical Epidemiology. Volume 10. 1839–1850. 6 indexed citations

Weng, Shu-Wen, Chien‐Chang Liao, Chun-Chieh Yeh, et al.. (2016). Risk of epilepsy in stroke patients receiving acupuncture treatment: a nationwide retrospective matched-cohort study. BMJ Open. 6(7). e010539–e010539. 20 indexed citations

Weng, Shu-Wen, Ta-Liang Chen, Chun-Chieh Yeh, et al.. (2016). An investigation of the use of acupuncture in stroke patients in Taiwan: a national cohort study. BMC Complementary and Alternative Medicine. 16(1). 321–321. 17 indexed citations

Weng, Shu-Wen, et al.. (2016). Traditional Chinese Medicine Use among Patients with Psoriasis in Taiwan: A Nationwide Population‐Based Study. Evidence-based Complementary and Alternative Medicine. 2016(1). 3164105–3164105. 35 indexed citations

Kuo, Chao-Lin, Kuang‐Chi Lai, Yi-Shih Ma, et al.. (2014). Gallic acid inhibits migration and invasion of SCC-4 human oral cancer cells through actions of NF-κB, Ras and matrix metalloproteinase-2 and -9. Oncology Reports. 32(1). 355–361. 52 indexed citations

Weng, Shu-Wen, Jai‐Sing Yang, Sakae Amagaya, et al.. (2013). Crude extract of Euphorbia formosana inhibits the migration and invasion of DU145 human prostate cancer cells: The role of matrix metalloproteinase-2/9 inhibition via the MAPK signaling pathway. Molecular Medicine Reports. 7(5). 1403–1408. 12 indexed citations

Hsu, Shu‐Chun, Shu-Wen Weng, Fu-Shin Chueh, et al.. (2013). Crude extract of Rheum palmatum inhibits migration and invasion of U-2 OS human osteosarcoma cells by suppression of matrix metalloproteinase-2 and -9. Biomedicine. 3(3). 120–129. 27 indexed citations

10.

Ma, Yi-Shih, Shu-Wen Weng, Meng-Wei Lin, et al.. (2012). Antitumor effects of emodin on LS1034 human colon cancer cells in vitro and in vivo: Roles of apoptotic cell death and LS1034 tumor xenografts model. Food and Chemical Toxicology. 50(5). 1271–1278. 112 indexed citations

11.

Lu, Kung-Wen, Jung-Chou Chen, Tung-Yuan Lai, et al.. (2011). Gypenosides Suppress Growth of Human Oral Cancer SAS Cells In Vitro and in a Murine Xenograft Model. Integrative Cancer Therapies. 11(2). 129–140. 33 indexed citations

12.

Lo, Chyi, Tung-Yuan Lai, Jai‐Sing Yang, et al.. (2011). Gallic acid inhibits the migration and invasion of A375.S2 human melanoma cells through the inhibition of matrix metalloproteinase-2 and Ras. Melanoma Research. 21(4). 267–273. 69 indexed citations

13.

Lu, Kung-Wen, Jung-Chou Chen, Tung-Yuan Lai, et al.. (2010). Gypenosides inhibits migration and invasion of human oral cancer SAS cells through the inhibition of matrix metalloproteinase-2 -9 and urokinase-plasminogen by ERK1/2 and NF-kappa B signaling pathways. Human & Experimental Toxicology. 30(5). 406–415. 51 indexed citations

14.

Lu, Kung-Wen, Jung-Chou Chen, Tung-Yuan Lai, et al.. (2010). Gypenosides causes DNA damage and inhibits expression of DNA repair genes of human oral cancer SAS cells.. PubMed. 24(3). 287–91. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact